Bayer said that its Astepro Allergy azelastine nasal spray is now available over the counter in US retail stores for the treatment of respiratory allergy symptoms in people aged 6 and older. The FDA approved Astepro Allergy for nonprescription use in June 2021.
Bayer Consumer Health US VP and General Manager of Upper Respiratory Catherine Vennat said, “At Bayer, our mission is to provide products that allow people to live healthier lives every day, and that means providing proven relief from their seasonal and indoor allergies symptoms any time they strike. Allergy sufferers now have access to the fastest, 24-hour nasal allergy medicine available OTC with steroid-free Astepro Allergy – a breakthrough in the category. With the sheer speed of our product, allergy sufferers can embrace the moment without worrying about when they will feel relief.”
Read the Bayer press release.
